Article thumbnail

Cancer vaccines

By A G Dalgleish
Topics: Millennium mini-review
Publisher: Nature Publishing Group
OAI identifier: oai:pubmedcentral.nih.gov:2374519
Provided by: PubMed Central

Suggested articles

Citations

  1. (1999). BCG immunotherapy of bladder cancer: 20 years on.
  2. (2000). Cancer vaccines 1623
  3. (1996). Comparison of IL-2 and IL-4 transfected B16-F10 cells with a novel oil-microemulsion adjuvant for B16-F10 whole cell tumour vaccine. Gene Therapy 3(10): 853–858 Souberbielle
  4. (1996). Is cancer dangerous to the immune system? Semin Immunol 8(5): 271–280 Gilboa E
  5. (1997). Role of Fas ligand (CD95L) in immune escape: the tumour cell strikes back.
  6. (1989). Studies on the mechanism of action.
  7. (1999). Tumour escape from the immune response: the last hurdle for successful immunotherapy of cancer? Cancer Immunol Immunother 48(7): 343–345

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.